2018年12月26日改訂版
以上
2023年3月31日(金)までメール添付( jca.office@imic.or.jp)で提出
申請書・推薦書様式はこちらからダウンロードできます。
ダウンロードした申請書・推薦書様式に入力後、プリントしていただき、推薦書には推薦者サインの上、 各書式をPDFに加工しメール添付で提出してください。
何か疑問点等がある場合には、下記事務局までお問合せください。
〒160-0016 東京都新宿区信濃町35 信濃町煉瓦館
一般財団法人国際医学情報センター内
一般社団法人 日本癌学会事務局
TEL 03-5361-7156(直通) FAX 03-3358-1633
e-mail:jca.office@imic.or.jp
Year | Categories | winner | affiliation | title of research |
---|---|---|---|---|
2022 | Innovative and/or disruptive research | Akihide Yoshimi | Section Head, Cancer RNA Research Unit, National Cancer Center Research Institute | Understanding and Targeting Aberrant RNA Splicing in Leukemias |
Translational Research | Mamiko Sakata-Yanagimoto | Professor, Department of Hematology, University of Tsukuba | Translational research targeting intractable lymphomas | |
2021 | Innovative and/or disruptive research | Shumpei Ishikawa | Professor, Department of Preventive Medicine, Graduate Shool of Medicine, The University of Tokyo | Genomic Characterization of Diffuse-type Gastric Carcinoma Life Cycle |
Translational Research | Hiromichi Ebi | Division Head, Division of Molecular Therapeutics, Aichi Cancer Center Research Institute | Development of targeted therapies against tumors with aberrant MAPK singnaling | |
2020 | Innovative and/or disruptive research | Hideaki Ogiwara | Chief, Division of Cancer Therapeutics, National Cancer Center Research Institute | Development of synthetic lethal therapy for chromatin regulator deficient cancers |
Translational research | Keisuke Kataoka | Chief, Division of Molecular Oncology, National Cancer Center Research Institute | Genetic dissection of molecular pathogenesis in human cancer | |
2019 | Translational research | Ryohei Katayama | Chief, Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research | Identification of the resistance mechanisms to molecular targeted therapies and immune checkpoint inhibitor in lung cancer |
Innovative and/or disruptive research | Shinichi Yachida | Professor, Department of Cancer Genome Informatic, Graduate School of Medicine, Osaka University | Cancer clonal evolution and involvement ot the microbiota in cancer development | |
2018 | Translational Research | Takahiro Maeda | Center for Celluar and Molecular Medicine/ Kyushu University Hospital | Identifying novel targets for leukemia therapy using the CRISPR/Cas9 gene-editing tool |
Other research area | Tatsushi Igaki | Laboratory of Genetics/ Graduate School of Biostudies Kyoto University | Mechanisms of cell-cell competition and cooperation in tumorigenesis | |
2017 | Basic | Yasuhiro Yamada | Laboratory of Stem Cell Oncology, Department of Life Science Frontiers, Center for iPS Cell Research and Application, Kyoto University | Dissecting cancer epigenetics with reprogramming technology |
Applied | Hiroyoshi Nishikawa | Division of Cancer Immunology, Research Institute/EPOC, National Cancer Center Department of Immunology, Nagoya University Graduate School of Medicine | Immune suppressive mechanisms as a target of effective cancer immunotherapy | |
2016 | Basic | Hidewaki Nakagawa | RIKEN Center for Integrated Medical Sciences, Laboratory for Genome Sequencing Analysis | Cancer Genomics for Molecular Diagnosis and Treatment: Genome Sequencing and Genome-wide Association Study |
Applied | Hiroyuki Seimiya | Division of Molecular Biotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research | Telomere maintenance system as an anticancer therapeutic target | |
2015 | Basic | Yutaka Kondo | Department of Epigenomics, Nagoya City University Graduate School of Medical Sciences | Targeting epigenetics as a new paradigm in cancer treatment |
Applied | Junko Takita | Department of Pediatrics, Graduate School of Medicine, The University of Tokyo | Identification of molecular therapeutic targets for pediatric cancers | |
2014 | Basic | Eiji Hara | Division of Cancer Biology, The Cancer Institute, Japanese Foundation for Cancer Research | Cellular senescence and cancer : a gut microbial connection |
Applied | Tatsuhiro Shibata | Division of Cancer Genomics, National Cancer Center Research Institute |
Identification and clinical translation of novel diagnostic and therapeutic targets in intractable solid cancers by cancer genome/transcriptome sequencing | |
2013 | Basic | Issay Kitabayashi | Division of Hematological Malignancy, National Cancer Center Research Institute | Molecular study of acute myeloid leukemia and its application for therapy |
Applied | Seiji Yano | Cancer Research Institute Kanazawa University | Circumvention of molecular targeted drug-resistance in lung cancer | |
2012 | Basic | Masanobu Oshima | Division of Genetics, Cancer Research Institute Kanazawa University | The role of inflammatory responses in gastric cancer development |
Applied | Shinji Tanaka | Tokyo Medical and Dental University, Department of Hepato-Biliary-Pancreatic Surgery | Surgical Oncology to Develop Novel Targeted Therapies for Advanced Digestive Cancer | |
2011 | Basic | Hirofumi Arakawa | Division of Cancer Biology, National Cancer Center Research Institute | Identification and characterization of p53 target genes |
Applied | Mineo Kurokawa | Department of Hematology and Oncology Graduate School of Medicine, University of Tokyo | Molecular pathogenesis and therapeutic targets of hematologcal malignancies | |
2010 | Basic | Seishi Ogawa | Cancer Genomics Project, Graduate School of Medicine University of Tokyo |
Identification of molecular targets in cancers through comprehensive cancer genome analysis |
Applied | Shin Maeda | Department of Gastroenterology, Yokohama City University | Analysis of NF-kB/IKK signaling pathways in liver carcinogenesis | |
2009 | Basic | Toshikazu Ushijima | Carcinogenesis Division National Cancer Center Research Institute |
Establishment of a novel concept "epigenetic field for cancerization", its mechanistic clarification, and clinical application |
2008 | Basic | Hidenori Ichijo |
Laboratory of Cell Signaling Graduate School of Pharmaceutical Sciences The University of Tokyo |
Stress Signaling and Cancer |
Applied | Hiroyuki Mano |
Division of Functional Genomics Jichi Medical University |
Discovery of a novel fusion-type oncogene EML4-ALK in lung cancer | |
2007 | Basic | Keiichi Nakayama | Department of Molecular and Cellular Biology Medical Institute of Bioregulation Kyushu University |
Ubiquitin ligases involved in cell-cycle control and cancer |
Applied | Minoru Toyota |
First Department of Internal Medicine Sapporo Medical University |
DNA methylation as a new target for therapy in cancer | |
2006 | Basic | Masanori Hatakeyama | Division of Molecular Oncology Institute for Genetic Medicine Hokkaido University |
The role of Helicobacter pylori CagA in gastric carcinogenesis |
Clinical | Johji Inazawa |
Department of Molecular Cytogenetics, Medical research institute Tokyo Medical & Dental University |
Exploring cancer-associated genes by molecular cytogenetic approach | |
2005 | Basic | Fuyuki Ishikawa | Laboratory of Cell Cycle Regulation Dept.of Gene Mechanisms, Graduate School of Biostudies Kyoto University |
Molecular of Chromosomal Evolution in Cancer Cells |
Clinical | Tetsuya Mitsudomi | Department of Thoroacic Surgery Aichi Cancer Center Hospital |
Molecular pathogenesis of? lung cancer and its clinical application |